Plasma metabolite biomarker could help identify who is at risk of a heart attack

Myocardial infarction, more commonly known as a heart attack, is a leading cause of death worldwide. Biomarkers called plasma metabolites may play a key role in the physiological pathways involved in myocardial infarctions. Recently published research used a methodological approach called bidirectional Mendelian randomization to understand more about these biomarkers and what they can tell doctors about heart attack risk.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup